<?xml version="1.0" encoding="UTF-8"?>
<p>The four serotypes of dengue virus (DENV1-DENV4), which belongs to the genus 
 <italic>Flavivirus</italic> of the family 
 <italic>Flaviviridae</italic>, cause the most important mosquito-borne viral disease in humans in the tropical and subtropical regions [
 <xref rid="pntd.0006879.ref001" ref-type="bibr">1</xref>,
 <xref rid="pntd.0006879.ref002" ref-type="bibr">2</xref>]. It has been estimated that more than 3 billion people living in more than 120 countries are at risk of DENV infection and approximately 390 million DENV infections occur annually worldwide [
 <xref rid="pntd.0006879.ref001" ref-type="bibr">1</xref>,
 <xref rid="pntd.0006879.ref002" ref-type="bibr">2</xref>]. While most DENV infections are inapparent or subclinical, approximately 25% result in clinical illness, ranging from a self-limited illness, known as dengue fever (DF), to more severe and potentially life-threatening disease, previously referred to as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [
 <xref rid="pntd.0006879.ref001" ref-type="bibr">1</xref>â€“
 <xref rid="pntd.0006879.ref003" ref-type="bibr">3</xref>]. In 2009, the World Health Organization revised the clinical case definition to dengue, dengue with warning signs, and severe dengue [
 <xref rid="pntd.0006879.ref003" ref-type="bibr">3</xref>].
</p>
